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Kinetic studies of dipeptide-based and amino acid-based peri- In peritoneal dialysis, a sterile electrolyte solution to-
toneal dialysis solutions. gether with an osmotic agent is instilled into the peri-
Background. Dipeptide-based peritoneal dialysis solutions toneal cavity with the aim of removing uremic toxins,
may have potential advantages compared with the glucose or
preserving electrolyte homeostasis and preventing accu-amino acid-based solutions. Dipeptides may hydrolyze in the
mulation of fluid. However, the solutions presently inperitoneal cavity, generating constituent amino acids and thereby
increasing the osmolality of the dialysate. Dipeptides can also use are far from ideal. Glucose, which is the most com-
be a valuable source of amino acids, which are poorly soluble monly used osmotic agent, has several drawbacks. Due
in water, such as tyrosine. to its low molecular weight, it is rapidly taken up by
Methods. Dwell studies in rats were performed during four
diffusive transport which renders it relatively inefficient,hours with dipeptide solutions containing five dipeptides (Gly-
especially in patients who are “high transporters,” thatHis, Ala-Tyr, Thr-Leu, Ser-Phe, Val-Lys), 8, or 16 mmol/L of
is, who have a peritoneal membrane with a high perme-each dipeptide (low or high dipeptide group). Dwell studies were
also performed with a 1.1% amino acid solution (Nutrinealt). ability for small molecules, necessitating the use of fre-
The model of dipeptide hydrolysis (hydrolysis rate, KH), diffu- quent exchanges with solutions having high glucose con-
sive (rate constant, KBDD) and convective transport as well as centrations to prevent fluid accumulation [1]. The glucose
transport of constituent amino acids consisted of mass balance
taken up from the dialysis solution may increase the totalequations, written for each dipeptide and amino acid.
energy intake, lead to obesity and changes in lipoproteinsResults. Peritoneal volume with the amino acid solution de-
that are potentially atherogenic [2]. Moreover, the highcreased much faster than that with the high and low dipeptide
solutions. KH for all dipeptides did not differ between the high concentration of glucose in peritoneal dialysis solutions
and low dipeptide groups. In the low dipeptide group, KH was could be detrimental because it may adversely affect the
0.004 6 0.004 mL/min (mean 6 SD) for Gly-His (the lowest) peritoneal membrane through glycosylation of proteinsand 0.088 6 0.048 mL/min for Thr-Leu (the highest). KBDD was or by other mechanisms [3].higher than KH for all dipeptides, the average being 0.2 6 0.05
A mixture of amino acids has also been successfullymL/min.
Conclusions. Dipeptides are hydrolyzed in the peritoneal introduced as an alternative osmotic agent in peritoneal
cavity, generating constituent amino acids. However, the hy- dialysis solutions [4]. By using an amino acid solution
drolysis rate appears to be several times lower than the dipep- for one or two exchanges a day, the number of exchanges
tide diffusive transport rate from dialysate to blood. Due to with glucose-containing solutions may be reduced. Aminothe higher molecular weight and intraperitoneal generation of
acids are absorbed from the dialysis fluid [5], and thisamino acids, the dipeptide-based solutions provide more sus-
may counteract dialytic protein and amino acid lossestained ultrafiltration than the amino acid solution. The plasma
concentration of amino acids at 60 minutes, in relation to the and provide an extra supply of amino acids, which may
dose of amino acids delivered between 0 and 60 minutes, is be advantageous as regards nutrition [6, 7], considering
considerably higher during the dwells with amino acid-based that protein malnutrition is a common problem in pa-
solution than during dwells with the dipeptide-based solutions.
tients with end-stage renal disease (ESRD). Amino acids
are also reported to be more biocompatible than glucose
regarding local effects on the peritoneal membrane [6, 8].Key words: dialysate, osmotic agents, end-stage renal disease, malnutri-
tion and PD, fluid homeostasis. However, amino acids are relatively small molecules (on
average about 140 daltons) and therefore have no advan-Received for publication April 14, 2000
tage over glucose as osmotic agents [9]. Moreover, lowand in revised form July 21, 2000
Accepted for publication July 26, 2000 solubility of some amino acids may be a limiting factor
in making an adequate amino acid solution from theÓ 2001 by the International Society of Nephrology
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Table 1. Composition of constituent amino acids innutritional point of view [10]. One such amino acid is
amino acid-based (Nutrineal) solution
tyrosine, which is considered essential in patients with
Molecular Concentrationrenal failure due to reduced generation from phenylala-
Amino acids weight mmol/Lnine [11]. However, dipeptides of tyrosine, such as ala-
Histidine 155.2 4.60nyl-tyrosine and glycyl-tyrosine have a higher solubility
Isoleucine 131.2 6.48
[12]. Glycyl-tyrosine has been added to amino acid solu- Leucine 131.2 7.77
Lysine 146.2 5.20tions for parenteral nutrition of patients with renal fail-
Methionine 184.7 4.60ure to increase the supply of tyrosine more than is possi-
Phenylalanine 165.2 3.45
ble with free tyrosine in the solution [2, 13]. Threonine 119.1 5.42
Tryptophan 204.2 1.32After a protein-rich meal, part of the protein is absorbed
Tyrosine 180.2 1.66from the gut as dipeptides, which are rapidly hydrolyzed
Valine 117.1 11.90
into their constituent amino acids [13]. Similarly, after Alanine 89.1 10.67
Arginine 174.2 6.15parenteral administration, dipeptides are rapidly metab-
Glycine 75.1 6.79olized and free amino acids are produced [10, 12].
Proline 115.1 5.17
Dipeptides might be useful as osmotic agents, since Serine 105.1 4.85
they have about twice as high molecular weight as amino Total — 86.03
acids and should therefore diffuse more slowly out of
Amino acids included in dipeptide solution are marked in bold.
the peritoneal cavity. They may even be hydrolyzed into
the constituent amino acids in the peritoneal cavity, thus
generating additional osmotically-active molecules, which
might further enhance ultrafiltration. Tyrosine-containing The three solutions had the following electrolyte com-
position: sodium, 132 mmol/L; calcium, 1.25 mmol/L;dipeptides may also be of benefit, since they may be pres-
ent in the dialysis fluid at higher concentrations than are magnesium, 0.25 mmol/L; lactate, 40 mmol/L; and chlo-
ride, 105 mmol/L.possible with free tyrosine.
In the present study, in a rat model we investigated The Dip 8 solution contained half as many moles of
dipeptides per liter as the number of moles of free aminothe diffusive and convective transport properties of the
peritoneum, using a dialysis solution containing an equi- acids in the amino acid-based solution (that is, the osmo-
lality of the amino acid-based solution was approxi-molar mixture of 5 dipeptides at two concentrations, and
compared the results with those obtained from a solution mately twice as high). Both the amino acid and the Dip
8 solutions had similar total amino acid contents. Thecontaining free amino acids. We also determined to what
extent the dipeptides were hydrolyzed to their constit- Dip 16 solution had similar total molar concentration as
the amino acid-based solution (that is, the osmolality wasuent free amino acids in the peritoneal cavity, the rate
of disappearance of dipeptides and amino acids from the approximately the same) but the amino acid content was
twice as high.peritoneal cavity, and the rate of appearance of amino
acids in plasma. Seven of the amino acids in the dipeptide solutions
were essential amino acids, that is, leucine, histidine, ly-
sine, phenylalanine, threonine, valine and tyrosine (tyro-
METHODS
sine is an indispensable amino acid in uremia), which
Solutions may be of potential nutritional benefit in future solutions.
Market availability and prices were considered whenThe following solutions were used: (1) an amino acid
solution (Nutrinealt, AA solution) containing 15 amino selecting the dipeptides to be used. By studying two di-
peptide solutions, one hypo-osmolal with the same aminoacids in varying proportions and with a total amino acid
concentration of 86 mmol/L (its composition is given in acid content as in the amino acid solution and one iso-
osmolal with double the amino acid content, we couldTable 1); (2) a weak (Dip 8) solution containing the five
dipeptides, glycyl-histidine (Gly-His), alanyl-tyrosine (Ala- analyze the properties of dipeptides as osmotic agents
and as providers of amino acids.Tyr), threonyl-leucine (Thr-Leu), seryl-phenylalanine
(Ser-Phe) and valyl-lysine (Val-Lys) in equimolar con-
Animalscentrations (8.4 mmol/L), with a total concentration of
dipeptides of 42 mmol/L [alanine-tyrosine was a kind Twenty-four male Sprague-Dawley rats with an aver-
age body weight of 300 g were divided into three groupsgift from Professor Peter Fu¨rst (Hohenheim University,
Stuttgart, Germany)and all other dipeptides were pur- (with 8 rats in each group). Each rat was anesthetized
with a single intraperitoneal injection of 50 mg/kg purechased from Sigma (St. Louis, MO, USA)]; (3) a strong
(Dip 16) solution containing the same five dipeptides in pentobarbital sodium (Pharmacia, Uppsala, Sweden).
The fur over the abdominal wall was closely shaved. Thedouble the amounts (16.8 mmol/L) with a total concen-
tration of 84 mmol/L dipeptides. animal was laid in a supine position and was kept at
Weryn´ski et al: Kinetic studies of peritoneal dialysis solutions 365
378C with a heating pad (CMA/Microdialysis, Stock- Chromatograms were integrated in a computerized data
system (Chromatography Data System AB, Stockholm).holm, Sweden). Isotonic saline, 1 mL/hour, was injected
subcutaneously to prevent hypovolemia. A multiholed
Calculationssilastic catheter (0.8 mm internal diameter; Venoflon,
Helsingborg, Sweden) was inserted percutaneously in Intraperitoneal dialysate volume (VD) was estimated
the left lower quadrant of the abdomen for dialysis fluid from the dilution of RISA with corrections made for the
infusion and sampling. The experiment was started by elimination of RISA from the peritoneal cavity and the
giving an intraperitoneal injection of 25 mL of 1.1% sample volume [15–18]. Note that the intraperitoneal vol-
amino acid dialysis solution (Nutrinealt, AA solution) ume at the end of the dwell was directly measured. The
or the weak (Dip 8) or strong (Dip 16) dipeptide solution, RISA elimination coefficient (KE) was calculated using
containing 18.5 KBq131 I-human serum albumin (RISA), a formula reported previously [15–18]. Since only a very
Isopharma AS, Kjeller, Norway) as a peritoneal volume small amount of free iodine was found in the RISA solu-
marker. The solutions were prewarmed to 378C before tion [19], we did not take the free iodine into account in
injection. the KE calculation. The actual calculations of KE and time
A priming dose of human serum albumin (final con- course of VD were performed using the computer pro-
centration 0.2 g/L) was added to the solutions to mini- gram PERTRAN (Baxter Novum, Karolinska Institutet,
mize the adhesion of tagged albumin to the surface of the Stockholm, Sweden), available at internet address: http://
catheter. After infusion, the dialysis solution remained in www.ibib.waw.pl/~peritome. The peritoneal fluid absorp-
the peritoneal cavity for four hours. Dialysate samples tion rate (QA, mL/min) was estimated as the coefficient
(0.35 mL) were taken at 0, 3, 15, 30, 60, 90, 120, 180 and of RISA elimination from the peritoneal cavity, KE. The
240 minutes postinfusion. Prior to each sampling, 1 mL transcapillary ultrafiltration rate (QU) was calculated as
of the dialysate was flushed back and forth five times the net volume change in time plus KE (Appendix II).
through the catheter. Blood samples were drawn at 0, The kinetic model developed for dipeptide transport
30, 60, 120 and 240 minutes from the tail artery. After and hydrolysis as well as transport of amino acids is shown
240 minutes, the peritoneal cavity was opened and dialy- in Figure 1 and described in Appendix I (Appendices I,
sate was collected, using a syringe and preweighed gauze II and III may be viewed in the online version of the jour-
tissues and the volume was recorded. The experimental nal at: http://dx.doi.org/10.1046/j.1523-1755.2001.00499.S).
study was approved by the Animal Ethics Committee of The method of estimating kinetic parameters is de-
Karolinska Institutet at Huddinge Hospital. scribed in Appendix II.
Dialysate samples (0.1 mL) were analyzed for RISA The amount (mass) of a particular amino acid trans-
activity on a Gamma Counter (Packard Instrument Com- ported from dialysate during the dwells with the amino
pany, Meriden, CT, USA) for 10 minutes each. The con- acid-based solution, between 3 and 120 minutes of the
centrations of amino acids and dipeptides in dialysate dwell, was calculated as follows:
and plasma were measured with high-pressure liquid chro-
DMA 5 VD(3)CDA(3) 2 VD(120)CDA(120)matography (HPLC; Waters, Milford, MA, USA).
Amino acid and peptide concentrations in dialysate where VD(3) and VD(120) are dialysate volumes at 3 and
and plasma were measured with reverse-phase HPLC, 120 minutes, respectively. CDA(3) and CDA(120) are amino
essentially as described by Suliman, Anderstam and Berg- acid concentrations at 3 and 120 minutes, respectively.
stro¨m for amino acids [14]. Briefly, samples were depro- The amount of total amino acids in the dialysate in
teinized with 5-sulfosalicylic acid, filtered and stored at dwells with dipeptide-based solutions was calculated as
2708C. The determinations of amino acids and dipep- the sum of the amount of dipeptide (mmol) and of con-
tides were carried out using fluorometric detection (Ex 5 stituent free amino acids (mmol). This calculation is valid
340 nm and 450 nm). The method was based on auto- only for amino acids contained in dipeptides in fresh
mated precolumn derivatization with orthophthalalde- dialysis solution. The amount of a particular amino acid
hyde/3-mercaptopropionic acid. Mobile phases used were transported from the dialysate in dwells with dipeptide-
solvent A [12.5 mmol/L phosphate buffer, pH 6.93, and based solution could therefore be calculated as:
tetrahydrofuran 99:1 (vol:vol)] and solvent B [methanol,
DMA 5 VD(3)[CDD(3) 1 CDA(3)]acetonitrile and deionized water 35:15:50 (vol:vol)]. A
chromatographic run lasted for 54 minutes. The HPLC
2 VD(120)[CDD(120) 1 CDA(120)]system (Waters Associate) consisted of a Waters system
where CDD(3) and CDD(120) are dipeptide concentrationscontroller 600E and two M-45 pumps, an auto-sampler
at 3 and 120 minutes, respectively, and CDA(3) and CDA(120)WISP-712B with a cooling system to optimize the tem-
are concentrations of free constituent amino acids at 3perature at 148C and a Waters 470 fluorescence detector.
and 120 minutes of the dwell. The reason for choosingThe amino acids and dipeptides were separated on a C18
column, 4.6 3 150 mm (YMC Co. Ltd, Kyoto, Japan). measurements at 120 minutes instead of 240 minutes,
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Fig. 1. Kinetic model of diffusive and convec-
tive transport of dipeptides and amino acids.
Nomenclature is: VD, peritoneal volume; CDD
and CBA, dialysate and blood dipeptide con-
centrations, respectively; CDA and CBA are con-
centrations of amino acids in dialysate and
blood plasma, respectively; KH, the hydrolysis
rate of dipeptide; KBDD and KBDA, diffusive
mass transport rate coefficients of dipeptides
and amino acids, respectively; QA, fluid ab-
sorption rate; QV, ultrafiltration flow rate. This
model does not include exchanges between
the blood and extravascular compartments.
the end of the study was that in most cases the dialysate more rapid than that with the Dip 16 solution and similar
dipeptide concentrations at 240 minutes were very low to that with the Dip 8 solutions. The average volume
and could not be measured with acceptable accuracy. decreases between 90 and 240 minutes of the dwells were
The relative changes in the concentration of amino 3.4 mL and 3.5 mL with Dip 8 and Dip 16 dipeptide-
acids in plasma were calculated as: based solutions, respectively, and 4.8 mL with the amino
acid-based solution.DCDA
DMA
In Figure 3, the time courses of the concentrations of
particular dipeptides and constituent amino acids in the
dialysate during dialysis with the dipeptide-based strong
5
CBA(60) 2 CBA(0)
VD(3)[CDD(3) 1 CDA(3)] 2 VD(60)[CDD(60) 1 CDA(60)] (Dip 16) solution are shown. The time courses of dipep-
tides and amino acids obtained with Dip 8 showed similar
CBA at 60 minutes was chosen, CBA(60), because the maxi- patterns (data not given). The dipeptides disappearedmal concentration of amino acids in plasma occurred at
approximately exponentially from the dialysate, whileabout 60 minutes. The results are expressed as mean 6
the concentrations of the constituent amino acids in-SD. Comparisons of normalized plasma amino acid con-
creased, due to their transport between blood and dialy-centrations were performed, using ANOVA and Student
sate and the cleavage of dipeptides occurring in the peri-t test for comparison of kinetic parameters. A P value
toneal cavity.of less than 0.05 was considered significant.
The kinetic model allowed for a fairly accurate quanti-
tative description of the complex processes of dipeptide
RESULTS hydrolysis in the peritoneal cavity, characterized by the
hydrolysis rate coefficient (KH), and dipeptide diffusionPeritoneal volumes (VD) over time curves, normalized
from the peritoneal cavity to plasma, characterized byby VD at 3 minutes [VD(3)] for the three dialysis solutions,
the diffusive mass transport coefficient (KBDD) (Fig. 1 andare shown in Figure 2. Dwells with the amino acid-based
Appendix I). Since the plasma dipeptide concentrationssolution exhibited an earlier maximum VD than with the
Dip 16 solution. The subsequent volume decrease was were negligible, the convective dipeptide transport by
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Fig. 2. Time courses of peritoneal volumes
(VD) during dwell studies with the dipeptide-
based solutions, Dip 16 (j) and Dip 8 (r),
and with the amino acid-based solution (m).
Fig. 3. Examples of concentrations of dipeptides and constituent amino acids in dialysate during dwell studies with the strong dipeptide-based
dialysis solution (Dip 16). DP and AA denote dipeptides and amino acids, respectively.
ultrafiltration was neglected. Convective flow of dipep- from dipeptides in the peritoneal cavity was described
as the product of dipeptide hydrolysis rate (KH) and CDD.tides from the dialysate was expressed as a product of
the fluid absorption rate (QA) and the dipeptide dialysate The model also included transport of constituent amino
acids between dialysate and plasma by diffusion (massconcentration (CDD). The generation rate of amino acids
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Table 2. Diffusive mass transport coefficients (KBDA, mean6SD)
for amino acids estimated using data from dwell study with the
amino acid-based dialysis solution
Molecular KBDA
Amino acid weight mL/min
Glycine 75.01 0.33460.096
Alanine 89.1 0.28260.069
Serine 105.1 0.26660.066
Valine 117.1 0.24360.053
Threonine 119.1 0.25560.134
Leucine 131.2 0.25160.072
Lysine 146.2 0.27560.128
Histidine 155.2 0.25160.061
Phenylalanine 165.2 0.24260.056
Tyrosine 180.2 0.23460.061
Fig. 4. Relationship between diffusive mass transport coefficients for
amino acids (KBDA, r) as well as dipeptides (KBDD, j) and molecular
weight of corresponding amino acids or dipeptides.
transport rate coefficient, KBDA) and convection from
plasma to dialysate, characterized by the sieving coeffi-
cients, SA, as well as convective absorption from the For each dipeptide, KBDD (or K*BDD) was much higher
than KH (or K*H; Tables 3 and 4). This means that transportdialysate, in which the sieving coefficient was assumed
to be one. The method for estimating a model’s parame- of dipeptides out of the peritoneal cavity occurs at a
much higher rate than the rate of hydrolysis. Statistically,ters is given in Appendix II.
Table 2 shows the average values of diffusive mass KH and K*H as well as KBDD and K*BDD showed no significant
differences, and both methods of estimating kinetic pa-transport coefficients (KBDA) for 10 amino acids that were
estimated from eight experiments with the amino acid- rameters for dipeptides seem to be equally accurate.
Since the concentration of dipeptides in blood was negli-based dialysis solution. The KBDA values for different
amino acids did not differ substantially (maximum value gible, there was no convective transport of dipeptides
from blood to dialysate with ultrafiltration flow and theof 0.334 6 0.096 mL/min for glycine and a minimum
value of 0.242 6 0.056 mL/min for phenylalanine). How- only convective transport was by fluid absorption from
the peritoneal cavity. The fluid absorption rate (QA) wasever, increasing molecular weight was accompanied by
decreasing values of KBDA (Fig. 4). estimated by the volume marker elimination rate (KE).
The average values of QA were estimated as 0.026 6 0.008The diffusive mass transport coefficients for dipeptides
(KBDD), estimated without any assumption concerning mL/min in dwells with the weak (Dip 8) dipeptide-based
solution and 0.031 6 0.005 mL/min in dwells with theamino acid transport, and K*BDD, estimated with KBDA taken
from amino acid-based dwell studies (Table 2), were strong (Dip 16) dipeptide-based solution. The average
values of QA did not differ statistically between the groups.calculated using data from the dwell studies with weak
and strong dipeptide-based dialysis solutions (Table 3). These values of QA were much smaller than the values
of KBDD (or K*BDD), reflecting that the convective transportThe difference between KBDD and K*BDD and the methods
used in estimation of their values are described in Ap- of dipeptides was very small as compared to the transport
by diffusion.pendix II. As shown in Table 3, the diffusive mass trans-
port coefficients for dipeptides, KBDD or K*BDD tended to Table 5 shows the amounts (masses), DMA, and the
fractional amounts of amino acids transported from thebe higher with the Dip 16 than with the Dip 8 solution.
Another characteristic feature is the dependence of KBDD dialysate, DMA/MA(3), where MA(3) is the amount of
amino acids at 3 minutes of the dwell. These fractional(or K*BDD) on dipeptide molecular weight. In Figure 4,
the diffusive mass transport coefficients for amino acids amounts were quite similar in the dwells with amino
acids and in the dwells with strong and weak dipeptide-(KBDA) and that for dipeptides (KBDD) estimated in dwells
with weak (Dip 8) solution are presented in reference to based solutions.
The time courses of blood concentrations of amino acidsthe corresponding molecular weights. KBDD estimated in
dwells with Dip 8 solution is probably better suited than exhibited an initial rise with maximum values achieved
after 30 or 60 minutes, followed by a gradual fall, as shownthat of Dip 16 for comparison with KBDA, because the
concentrations of amino acids in the amino acid solution in Figure 5. This pattern was observed in all dwell studies.
Histidine, lysine, threonine and serine showed very simi-and of dipeptides in the Dip 8 solution are more similar.
The hydrolysis rate coefficients for the five dipeptides lar plasma amino acids concentration time courses during
dwells with the amino acid solution and Dip 8 solution.are presented in Table 4. It should be noted that the
lowest KH values were found for Gly-His with both the We also wished to determine whether the increase in
plasma concentrations in relation to the uptake of aminoweak and the strong dipeptide-based solutions.
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Table 3. Diffusive mass transport rate coefficients for dipeptides (KBDD) estimated using data from dwell studies with weak (Dip 8) and
strong (Dip 16) dipeptide-based dialysis solutions
KBDD mL/min K*BDD mL/minMolecular
Dipeptide weight Dip 8 Dip 16 Dip 8 Dip 16
Thr-Leu 232.3 0.23160.084 0.26460.142 0.19760.071 0.24760.125
Gly-His 248.7 0.20560.050 0.20760.118 0.21260.054 0.20960.118
Ala-Tyr 252.3 0.21960.064 0.23060.122 0.20160.056 0.21760.106
Ser-Phe 252.3 0.18560.070 0.22860.116 0.16560.065 0.19360.097
Val-Lys 281.8 0.17260.040 0.19760.116 0.16560.040 0.20260.116
K*BDD was calculated with KBDA for amino acids estimated using the amino acid kinetic model and data from amino acid-based dialysis solution (Table 2). Data
are mean 6 SD for KBDD and K*BDD.
Table 4. Intraperitoneal hydrolysis rate coefficients for dipeptides
(KH) estimated with data from dwell studies of weak (DIP 8) and
strong (DIP 16) dipeptide-based dialysis solutions
KH mL/min K*H mL/min
Dipeptide Dip 8 Dip 16 Dip 8 Dip 16
Thr-Leu 0.05460.036 0.05360.018 0.08860.048 0.07260.024
Gly-His 0.01260.006 0.00660.005 0.00460.009 0.00460.004
Ala-Tyr 0.06660.027 0.04260.010 0.08460.034 0.05860.014
Ser-Phe 0.05660.027 0.06060.037 0.07660.036 0.09960.074
Val-Lys 0.03260.017 0.02360.014 0.03960.025 0.01860.018
K*H was calculated with KBDA estimated using the amino acid kinetic model
and data from the amino acid-based dialysis solution. Data are mean 6 SD.
Fig. 5. Time courses of the concentration of one selected amino acid,
histidine, in plasma during dwell studies with the Dip 16 (j), Dip 8
acids differs, depending on whether the amino acids are (r) solutions, and the amino acid-based (m) solution.
given in the solution in free form or as dipeptides. To
study this, the amount (mass) transported from the dialy-
sate (DMA) of histidine, lysine, threonine and serine,
DISCUSSIONduring dwells with the amino acid solution were com-
The reduction in dialysate volume between 90 andpared to the DMA of the same amino acids during dwells
240 minutes with the strong (Dip 16) dipeptide-basedwith the Dip 8 solution. As shown in Table 5, the DMA
solutions was less rapid than that with the amino acid-was substantially higher for each of these amino acids
based solution (Fig. 2), in spite of the initial osmolalitywith Dip 8 than with the amino acid-based solution (for
being very similar. This seems to be caused by the higherhistidine 2.83 times higher, P , 0.0001; for threonine,
molecular weight of the dipeptides and generation of3.47, P 5 0.0001; for serine, 1.84, P 5 0.0005; and for
constituent amino acids from hydrolysis of dipeptides inlysine, 2.45, P 5 0.0019). However, despite these large
the peritoneal cavity.differences, the plasma concentrations were very similar
The reason why the weak dipeptide-based solution
during the two dwells.
results in a similar pattern of peritoneal volume changes
Another way to show the relationship between the as the amino acid-based solution (Fig. 2), despite having
plasma concentration of an amino acid and the dose of half the molar concentration, may be that: (1) the diffu-
that amino acid transported from the peritoneal cavity sive mass transport coefficient for dipeptides (KBDD) is
is shown in Table 6. Here the increases in plasma amino smaller than the KBDA for amino acids (Fig. 4); and (2)
acid concentrations at 60 minutes, DCBA(60), represent- dipeptides are hydrolyzed in the peritoneal cavity (al-
ing values close to the maximum, are divided by the mass though at lower rate than the rate of their transport from
of amino acids transported from the peritoneal cavity dialysate; compare Tables 3 and 4), which generates free
between 3 minutes and 60 minutes (DMA). For all amino amino acids during the dwell. The driving force for changes
acids except phenylalanine, the mean DCBA(60)/DMA in in peritoneal volume is the difference in concentration
the amino acid-based dwell studies was higher than in of an osmotic agent between dialysate and plasma. In
the dipeptide-based dwell studies. The difference was the case of dipeptide-based dialysis, this driving force
statistically significant for glycine, histidine, leucine and can be approximately expressed as the concentrations
(molar) of dipeptides plus concentrations of constituentvaline.
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Table 5. Average masses (DMA) fractional average masses [DMA/MA(3)] of amino acids transported from the dialysate between 3 and 120
minutes of the dwell with the amino acid-based solution (AA sol) as well as weak (Dip 8) and strong (Dip 16) dipeptide-based solutions
Dip 8 Dip 16 AA sol
DMA DMA DMA
lmol
DMA
MA(3) lmol
DMA
MA(3) lmol
DMA
MA(3)
Glycine 118.4623.3 0.6360.10 215.7625.6 0.6560.05 86.0624.2 0.6860.10
Histidine 120.7623.9 0.6460.10 219.6625.9 0.6760.06 42.7613.9 0.6060.11
Alanine 107.9624.0 0.6360.11 229.1630.0 0.6760.06 106.4626.1 0.6360.10
Tyrosine 107.5623.1 0.6360.11 230.0631.3 0.6760.06 15.364.47 0.5760.10
Threonine 169.5658.2 0.7160.20 318.3666.6 0.7060.08 48.9623.5 0.6160.11
Leucine 157.5651.4 0.6760.18 318.6663.1 0.7060.08 76.6618.6 0.6160.11
Serine 90.4623.8 0.5860.09 260.8648.1 0.6960.08 49.0610.7 0.6160.09
Phenylalanine 88.2624.6 0.5660.09 230.2660.3 0.6160.13 34.368.2 0.6260.10
Valine 121.9642.4 0.5460.09 351.7682.8 0.6660.11 108.3629.0 0.6060.10
Lysine 126.8653.2 0.5660.12 340.2662.3 0.6560.08 51.7616.4 0.5860.13
Table 6. Increase in amino acid concentration in plasma between between the weak (Dip 8) and strong (Dip 16) dipeptide-
0 and 60 minutes of the dwell normalized by the mass of amino based solutions for the various dipeptides. The hydrolysisacids delivered between 3 and 60 minutes of the dwell, DCBA/DMA
rates, (KH or K*H) were of the same order for all dipep-(mean 6 SD), with the amino acid-based solution (AA sol) as
well as weak (Dip 8) and strong (Dip 16) dipeptide-based solutions tides, except Gly-His, which had much lower values (Ta-
ble 4).DCBA/DMA L21
The decline of dipeptide concentration as shown inAA sol Dip 8 Dip 16
Figure 3 is due to dipeptide diffusion from the peritoneal
Glycine 3.0861.80a 1.0960.77 1.4660.39 cavity and dipeptide hydrolysis. The contribution of dif-Histidine 3.8462.37a 2.1460.57 1.9960.47
fusion alone to this decline can be assessed by a ratio ofAlanine 3.7462.53 2.6962.39 0.9861.02
Tyrosine 3.3962.42 3.0561.70 2.6860.53 diffusive mass transport coefficient for dipeptide, KBDD,
Threonine 7.0665.95 2.2860.82 2.8760.96 to the sum of KBDD and the hydrolysis rate, KH. UsingLeucine 6.4262.95a 1.7760.28 1.8360.82
this assessment it can be shown that diffusion contributedSerine 3.3061.93 2.8261.35 2.1660.66
Phenylalanine 1.9561.22 2.4861.30 1.4960.53 from 73% (for Ser-Phe) to 98% (for Gly-His) to the
Valine 6.5563.27a 3.6962.04 3.0760.83 dipeptide concentration decline, whereas 27% and 2%,Lysine 6.0562.76 5.6762.16 4.0661.56
respectively, of the decline was due to hydrolysis.
a Significant differences between AA sol and Dip 8 and Dip 16
The higher concentration curve for glycine than for
histidine in the dialysate, shown in Figure 3, is difficult to
explain, since hydrolysis of the Gly-His dipeptide should
amino acids in the dialysate, minus the concentrations result in the generation of equimolar amounts of the two
of corresponding amino acids in blood plasma. As the amino acids and diffusive transport of histidine should
diffusive mass transport parameters of the dipeptides and be lower than that of glycine, due to its more than twice
amino acids depend on their molecular weights (Fig. 4) higher molecular weight. One possibility might be that
and the hydrolysis rates of the dipeptides are similar histidine removal from the peritoneal fluid is enhanced
(except that of Gly-His), we chose Thr-Leu, which has a by its adsorption to peritoneal membrane structures. A
representative molecular weight of dipeptide and constit- higher concentration of serine than phenylalanine was
uent amino acids (Tables 2 and 3) as an example to illus- also observed; in this case the much lower molecular
trate the changes in the peritoneal volume driving force. weight of serine might lead to more rapid removal by
The driving force of this single dipeptide in dwells with diffusion than for phenylalanine.
Dip 8 solution divided by the value of the driving force In Figure 4, the pattern of decreasing KBDA and KBDD
at 3 minutes was constantly higher after 60 minutes than with increasing molecular weight is clearly seen. This ob-
that generated by threonine or leucine in the amino acid- servation is in general agreement with thermodynamic
based solution. At 180 minutes, it was 0.35 6 0.10 (mean 6 theory, that solutes of higher molecular weight diffuse
SD) mmol/L for threonine-leucine, 0.23 6 0.12 mmol/L more slowly than solutes of lower molecular weight. It is
for threonine and 0.20 6 0.10 mmol/L for leucine. interesting to note that KBDD and K*BDD from the dwells
The average values of KH and K*H as well as the values with the strong (Dip 16) dipeptide-based solution tended
of KBDD and K*BDD showed no significant differences. This to be higher than KBDD and K*BDD from the dwells with the
analysis confirms that the accuracy of estimating kinetic weak (Dip 8) dipeptide-based solution (Table 3). The
parameters for amino acids has little effect on the estima- reason for this difference is not clear; however, a similar
tion of dipeptide kinetic parameters. No significant dif- phenomenon was observed in a study with 1% and 2.7%
amino acid-based solutions in uremic patients [5].ferences were noted in the hydrolysis rates (KH or K*H)
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An unexpected finding was that, in the case of four supply amino acids with a moderate increase in plasma
amino acid concentration.amino acids (histidine, lysine, threonine and serine), the
absolute amount of amino acid transported from dialy-
Reprint requests to Professor Jonas Bergstro¨m, Divisions of Baxter
sate during the dwells with the weak (Dip 8) dipeptide- Novum and Renal Medicine, K-56 Huddinge Hospital, S-14186 Hud-
dinge, Sweden.based solution was about three times higher than that
E-mail: jonas.bergstrom@kfcmail.hs.sll.seobserved during the dwells with the amino acid-based
solution, although the plasma concentration of these
amino acids was similar during the dwells with the weak APPENDIX I
dipeptide-based solution and during those with the amino Kinetic model for dipeptides and its constituent amino acids
acid-based solution (Fig. 5). Moreover, for all amino Following instillation of the dipeptide-based dialysis solution in the
acids except phenylalanine, the increase in plasma con- peritoneal cavity in rats, measurements of dipeptide and amino acid
concentrations were performed in dialysate and blood. Since dipeptidescentration at 60 minutes in relation to the dose delivered
were not detected in blood it could be assumed that they were rapidlybetween 0 and 60 minutes was considerably higher dur- hydrolyzed in blood (or deposited in tissues) and their concentration
ing the dwells with the amino acid-based solution than in blood was therefore assumed to be zero.
A schematic diagram of diffusive transport of dipeptides, generationduring those with the two dipeptide-based solutions (Ta-
of amino acids by hydrolysis of dipeptides and diffusive transport ofble 6). From these findings it can be inferred that dipep- constituent amino acids is shown in the upper left part of Figure 1.
On the right side are presented corresponding differential equationstide-based solutions may provide a method of delivering
of the kinetic model. In the lower section of Figure 1, the diagramamino acids during dialysis with a smaller change in
and corresponding equations for convective transport of dipeptides
plasma amino acid concentrations than during dialysis and amino acids are shown. The sum of diffusive and convective trans-
port yields the total transport.with an amino acid-based solution.
The mass balance equation for dipeptides is therefore as follows:The reason for this difference between amino acid
and dipeptide-based solutions is not clear. A possible d(VDCDD)
dt
5 2(KH 1 KBDD)CDD 2 QACDD (Eq. 1)
explanation may be that amino acids, in the form of
dipeptides, delivered to the splanchnic area from dialysis where CDD is the dipeptide concentration in dialysate. The fluid absorp-
tion rate (QA) is estimated by the RISA elimination coefficient (KE).fluid are taken up in the liver more efficiently (with less
VD and KE were evaluated as described in the Calculation section.delivery to the peripheral circulation) than the corre- The net coefficient, KH 1 KBDD, was estimated using equation 1. This
sponding free amino acids. Another explanation could equation does not allow an estimation of KH and KBDD separately, and
for this purpose a kinetic model for amino acids is needed.be that dipeptides are not immediately hydrolyzed in
After hydrolysis, each dipeptide molecule generates two molecules
blood (as can be inferred from undetectable dipeptide of constituent amino acids. Therefore, each dipeptide produces two
equal input flows for constituent amino acids in the peritoneal cavity,blood concentrations), but rather are rapidly stored in
each equal to KHCDD.the blood vessel walls (or peritoneal tissue) and slowly
Amino acids are transported between the dialysate and plasma by
hydrolyzed [20]. diffusion and the diffusive flow for each amino acid can be described
as a product of the diffusive mass transport coefficient KBDA and theConceivably, some of the adverse effects of amino
concentration difference between plasma and dialysate for this aminoacids, such as loss of appetite, nausea and vomiting, are
acid. The convective flow of a particular amino acid from plasma to
related to the concentrations of amino acids in blood, dialysate can be expressed as a product of the ultrafiltration flow rate,
QU, amino acid sieving coefficient, SA, and the average amino acidwhich may have effects mediated in the splanchnic area
concentration, C¯A, calculated as an arithmetic mean of blood, CBA, andor in centers regulating appetite and satiety in the central
dialysate, CDA, amino acid concentrations, C¯A 5 (CBA 1 CDA)/2. The
nervous system [21, 22]. If this is the case, dipeptide- convective flow of amino acids from the peritoneal cavity can be de-
scribed as a product of the fluid absorption rate, QA, and CDA; nobased PD solutions should be advantageous because they
sieving of amino acid in the convective flow from peritoneal cavitypermit delivery of larger amounts of amino acids with was assumed (SA 5 1). The mass balance equation for each amino acid
fewer side effects than do amino acid-based solutions. produced in the peritoneal cavity by dipeptide hydrolysis is therefore
as follows:In summary (1) intraperitoneal dialysate volume de-
creases more slowly between 90 and 240 minutes during d(VDCDA)
dt
5 KHCDD 1 QUSAC¯A 2 KBDA(CDA 2 CBA) 2 QACDAa dwell with dipeptide-based solutions than with amino
acid-based solutions; (2) dipeptides are hydrolyzed in (Eq. 2)
the peritoneal cavity, but at a much lower rate than the
Note that each mass balance equation for a particular dipeptide (Eq. 1)
rate of diffusive transport from the peritoneal cavity; is accompanied by two mass balance equations for constituent amino
acids (Eq. 2) with an identical amino acid generation rate, KHCDD.(3) diffusive mass transport coefficients for amino acids
(KBDA) and for dipeptides (KBDD) show a clear depen-
dence on their molecular weights; (4) hydrolysis rate APPENDIX II
coefficients for dipeptides in the peritoneal cavity differ Estimation of kinetic parameters
between various dipeptides, which may be due to differ-
Integration and rearrangement of equation 1 yields:ent affinities of particular dipeptides to the hydrolysis
Y1(tn) 5 (KH 1 KBDD)X1(tn) (Eq. 3)enzyme; and (5) dipeptide-based solutions may be a bet-
ter way, as compared to amino acid-based solutions, to where
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(or K*H), and the diffusive mass transport coefficient for dipeptide, KBDDY1(tn) 5 VD(tn)CDD(tn) 2 VD(t0)CDD(t0) 1 QA #
tn
t0
CDD dt
(or K*BDD), is enhanced by the fact that for every dipeptide KH was
estimated twice, using equation 5, for two different amino acids gener-and
ated from the single dipeptide. The reported values for KH or K*H are
X1(tn) 5 2#
tn
t0
CDD dt the arithmetic average of these two estimates.
where t0 and tn are the initial and consecutive, n-th, time points in
which measurements have been made, respectively. Y1(tn) and X1(tn) APPENDIX III
were calculated using the available measurements, and then KH 1 KBDD Nomenclaturewas estimated using linear regression.
Integration and rearrangement of equation 2 yields VD peritoneal volume in mL or L.
CDD dipeptide concentration in dialysate in mmol/L or mmol/L.Y2(tn) 5 KBDAX2(tn) 1 SAX3(tn) 1 KHX4(tn) (Eq. 4)
CBA amino acid concentration in plasma in mmol/L or mmol/L.
CDA amino acid concentration in dialysate mmol/L or mmol/L.where
C¯A arithmetic mean of amino acid concentrations in plasma and
Y2(tn) 5 VD(tn)CDA(tn) 2 VD(t0)CDA(t0) 1 QA #
tn
t0
CDA dt dialysate in mmol/L or mmol/L.
QA fluid absorption rate in mL/min.
X2(tn) 5 #
tn
t0
(CBA 2 CDA)dt QU ultrafiltration flow rate (ml/min).
KE elimination coefficient of a volume marker in mL/min.
KH rate coefficient of dipeptide hydrolysis in mL/min. EstimatedX3(tn) 5 #
tn
t0
C¯AQU dt
without any assumption concerning amino acid transport coef-
ficients.X4(tn) 5 #
tn
t0
CDD dt 5 2X1(tn) K*H rate coefficient of dipeptide hydrolysis in mL/min. Estimated
with assumption that diffusive mass transport coefficient of
amino acids, KBDA, in dwells with the dipeptide-based solu-Y2(tn), X2(tn) and X4(tn) could be calculated using available measure- tions is the same as in dwells with the amino acid-based solu-ments, X3(tn) was calculated with the following estimate of ultrafiltra- tion.tion flow rate QU. KBDA coefficient of diffusive mass transport between dialysate and
plasma of amino acid in mL/min. Estimated using data from
QU(tn) 5
dVD
dt u
tn
1 QA >
VD(tn) 2 VD(tn21)
tn 2 tn21
1 KE dwells with the amino acid-based solution.
KBDD coefficient of diffusive mass transport between dialysate and
plasma of dipeptide in mL/min. Estimated without any as-Using equation 4 and multiparameter linear regression, the parame-
sumption concerning amino acid transport coefficients.ters, KBDA, SA, and KH were estimated. Having estimated KH with equa- K*BDD coefficient of diffusive mass transport between dialysate andtion 4, and (KH 1 KBDD) with equation 3, KBDD was calculated. The plasma of dipeptide in mL/min. Estimated with assumptionintegrals in equations 3 and 4 were calculated, using linear interpolation
that diffusive mass transport coefficient of amino acids, KBDA,between data points.
in dwells with dipeptide-based solution is the same as inThese calculations showed that some kinetic parameters pertaining
dwells with amino acid-based solution.to amino acid transport in the dipeptide-based dwells had unacceptable
SA sieving coefficient of amino acid (dimensionless).values. For some amino acids, KBDA became negative and SA outside MA mass (amount) of amino acid in mmol.of an acceptable range of 0 to 1 (data not shown). Nevertheless, kinetic
D change (difference).parameters pertaining to dipeptide hydrolysis, HH, and diffusive trans- RISA volume marker, 131I-human serum albumin.port between dialysate and blood, KBDD, showed acceptable values and
are reported in this study.
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